PERSPECTA

News from every angle

Back to headlines

Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion in Pharma Mega-Deal

Vertex Pharmaceuticals has signed an agreement to acquire Crinetics Pharmaceuticals for $10 billion, marking another significant merger in the pharmaceutical industry. This acquisition is set to expand Vertex's portfolio.

7 Jul, 10:55 — 7 Jul, 10:55
PostShare

Sources

Showing 1 of 2 sources